"Receptors, CCR6" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
CCR receptors with specificity for CHEMOKINE CCL20. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; and DENDRITIC CELLS.
| Descriptor ID |
D054399
|
| MeSH Number(s) |
D12.776.543.750.695.160.150.600 D12.776.543.750.705.852.125.150.600
|
| Concept/Terms |
Receptors, CCR6- Receptors, CCR6
- CCR6 Receptors
- Antigens, CD196
- CC Chemokine Receptor 6
- CC Chemokine Receptors 6
- CD196 Antigens
|
Below are MeSH descriptors whose meaning is more general than "Receptors, CCR6".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Chemokine [D12.776.543.750.695.160]
- Receptors, CCR [D12.776.543.750.695.160.150]
- Receptors, CCR6 [D12.776.543.750.695.160.150.600]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Chemokine [D12.776.543.750.705.852.125]
- Receptors, CCR [D12.776.543.750.705.852.125.150]
- Receptors, CCR6 [D12.776.543.750.705.852.125.150.600]
Below are MeSH descriptors whose meaning is more specific than "Receptors, CCR6".
This graph shows the total number of publications written about "Receptors, CCR6" by people in this website by year, and whether "Receptors, CCR6" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, CCR6" by people in Profiles.
-
Enrichment of CCR6+ CD8+ T cells and CCL20 in the lungs of mechanically ventilated patients with COVID-19. Eur J Immunol. 2021 06; 51(6):1535-1538.
-
Characterization of T lymphocytes in severe COVID-19 patients. J Med Virol. 2021 09; 93(9):5608-5613.
-
Identification of human immune cell subtypes most responsive to IL-1ß-induced inflammatory signaling using mass cytometry. Sci Signal. 2021 03 09; 14(673).
-
Circulating CXCR3-CCR6-CXCR5+CD4+ T cells are associated with acute allograft rejection in liver transplantation. Immunol Lett. 2019 09; 213:55-61.
-
CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer. Exp Cell Res. 2018 11 15; 372(2):168-177.
-
CCL20 blockade increases the severity of nephrotoxic folic acid-induced acute kidney injury. J Pathol. 2018 10; 246(2):191-204.
-
Integrin a4ß7 Blockade Preferentially Impacts CCR6+ Lymphocyte Subsets in Blood and Mucosal Tissues of Naive Rhesus Macaques. J Immunol. 2018 01 15; 200(2):810-820.
-
Immunopathogenesis of IBD: Batf as a Key Driver of Disease Activity. Dig Dis. 2016; 34 Suppl 1:40-7.
-
CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals. Mucosal Immunol. 2016 09; 9(5):1137-50.
-
CCL20 and ß-defensin-2 induce arrest of human Th17 cells on inflamed endothelium in vitro under flow conditions. J Immunol. 2011 Feb 01; 186(3):1411-20.